Close Menu

NEW YORK (GenomeWeb) – Angle said today that it intends to acquire certain assets, including intellectual property, fixed assets, inventory, employees, and a property leasehold interest, from University of Toronto microarray spinout Axela, for a total of £3.7 million ($4.9 million).

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.


As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.